Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AC Immune (ACIU) Receivables - Net: 2023-2024

  • AC Immune's Receivables - Net was N/A to $28.4 million in Q3 2024 from the same period last year, while for Sep 2024 it was $28.4 million, marking a year-over-year change of. This contributed to the annual value of $16.7 million for FY2023, which is N/A change from last year.
  • AC Immune's Receivables - Net amounted to $28.4 million in Q3 2024, which was up 70.18% from $16.7 million recorded in Q4 2023.
  • Over the past 5 years, AC Immune's Receivables - Net peaked at $28.4 million during Q3 2024, and registered a low of $16.7 million during Q4 2023.
  • In the last 2 years, AC Immune's Receivables - Net had a median value of $22.5 million in 2024 and averaged $22.5 million.